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Halothane administration during liquid ventilation 
D. B. KIMLESS-GARBER, M. R. WOLFSON, C. CARLSSON AND T. H. SHAFFER 
Departments of Physiology, Pediatrics and Anesthesiology, Temple University School of Medicine, 
Philadelphia, PA 19140, U.S.A. 
The objective of this study was to test the hypothesis that perfluorochemical (PFC) liquid ventilation 
(LV) can be used as a vehicle to deliver halothane and induce and maintain analgesia. Seven hamsters 
were paralysed and stabilized with mechanical gas ventilation, ventilated in alternating cycles with gas 
and either neat oxygenated PFC liquid or oxygenated PFC liquid mixed with liquid halothane (PFC:hal) 
1.50%) (volumekapour); arterial pressure and blood gases were monitored throughout the protocol. 
After each cycle, the animal was stimulated with a foot clamp for 2 s. Mean arterial pressure 
(MAP:mmHg) response to this stimulation (percent change from the resting MAP) was used as an index 
of analgesia. Mean arterial pressure was significantly lower during ventilation with PFC:hal (73 & 7 SE) 
as compared with MAP during neat PFC (113 f 5 SE) or gas ventilation (107 i SE). Mean arterial 
pressure response (o/o change in MAP from baseline) to foot-clamp stimulation was significantly lower 
with PFC:hal ventilation (+ 12 & 5% SE) as compared with neat PFC (+28 f 8% SE) and gas ventilation 
(+ 29 419% SE). There was no statistically significant difference in resting MAP or MAP response to 
foot-clamp stimulation between cycles of ventilation with neat PFC alone or gas ventilation; arterial 
blood gases were not significantly different between modes of ventilation or levels of analgesia. The data 
indicate that halothane can be administered during LV while supporting gas exchange, and demonstrate 
the feasibility of inducing analgesia while using PFC LV techniques. 
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Introduction 
Perfluorochemical (PFC) liquid ventilation (LV) 
has been successfully employed to reduce surface 
tension, insufflate the lung at lower alveolar 
pressures than gas ventilation, support gas 
exchange, and deliver biological agents in pre- 
mature, newborn and adult animals with respir- 
atory distress (l-8). A recent clinical study 
demonstrated the feasibility of PFC LV treat- 
ment in human premature neonates with respir- 
atory distress (9,lO). Patients ventilated with 
PFC may require induction and maintenance 
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of analgesia for surgical procedures. It has been 
demonstrated previously that a fluorinated 
hydrocarbon (such as halothane) is miscible and 
soluble in PFC (11). As the PFC liquid can be 
homogeneously distributed throughout the lung 
at low inflation pressures, PFC ventilation tech- 
niques may also provide an effective means of 
inducing and maintaining analgesia while sup- 
porting gas exchange at lower risk of baro- 
trauma. Therefore, the objective of this study 
was to test the hypothesis that PFC ventilation 
can be used as a vehicle to deliver halothane 
and induce analgesia. Halothane was selected 
because of its common use in paediatric clinical 
practice and in animal studies. 
Methods 
Seven adult female hamsters (Mesocvicetus 
auratus), weighing 125.7 f 9 g SD, were studied. 
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The study was conducted according to standards 
of the Animal Research Review Committee of 
Temple University School of Medicine. 
ANIMAL PREPARATION 
After administration of intraperitoneal sodium 
pentobarbital (30 mg kg - ‘), a cannula was 
inserted through a tracheotomy midway along 
the trachea with its tip positioned proximal to 
the carina. The trachea was secured to the can- 
nula to avoid leakage in the ventilatory system. 
The femoral vein was cannulated for venous 
access and the carotid artery was cannulated for 
arterial blood pressure and blood gas assess- 
ment. Subcutaneous needle electrodes were 
placed for electrocardiogram recording of heart 
rate (HR). A rectal thermometer was placed 
to monitor temperature. A radiant heart 
source was adjusted to maintain the animal’s 
temperature between 37 and 38°C. The animals 
were paralysed with vercuronium bromide 
(0.1 mg kg - ’ h - ‘) and mechanically ventilated 
with a Harvard Apparatus rodent respirator 
(F,O,= 1) to maintain oxygenation and carbon 
dioxide elimination. Arterial blood gas tensions 
and pH were determined on 0.10 ml whole blood 
samples utilizing a Radiometer ABL 330 ana- 
lyser, corrected to the animal’s temperature. 
Withdrawn blood volume was replaced intra- 
venously with warmed normal saline solution. 
Ventilator settings (tidal volume and rate) were 
adjusted to normalize arterial blood gas ten- 
sions; pH was adjusted by sodium bicarbonate 
administration if the pH was ~7.25 and the 
PaCO, I 50 mmHg ([mEq base added= - base 
excess (mEq 1 - ‘) x body weight x 0.31) (12). 
Arterial blood pressure was measured by con- 
necting the carotid artery catheter to a Statham 
transducer. Blood pressure and HR were 
recorded continuously on a recorder (Electronics 
for Medicine). 
LIQUID VENTILATION SYSTEM 
The liquid ventilation system (LVS) was based 
on the gravity-assist principle and is schemati- 
cally shown in Fig. 1. Briefly, tidal volumes of 
the liquid are exchanged between the reservoirs 
(inspiratory and expiratory) and the animal’s 
lungs under a hydrostatic pressure created by the 
FIG. 1. Gravity-assisted liquid ventilation system. 
relative heights of the reservoirs to the animal’s 
thorax. The entire circuit was filled with liquid 
PFC (RIMAR 101: Miteni; Milano, Italy). The 
PFC was warmed (39”) and oxygenated 
(>600 mmHg) at the inspiratory reservoir. The 
inspiratory limb extended from a 50 ml gradu- 
ated cylinder reservoir, suspended above the 
animal’s thorax, and was attached to one end of 
a T-piece which was connected to the tracheos- 
tomy tube. The expiratory limb extended from 
the T-piece into a 50 ml graduated cylinder res- 
ervoir. To begin LV, a functional residual ca- 
pacity of PFC (20 ml kg - ‘) was instilled in the 
lung from the inspiratory reservoir. Subse- 
quently, the heights of the inspiratory (30- 
60 cm) and expiratory ( - 20- - 30 cm) 
reservoirs were adjusted so that liquid volumes 
exchanged between the lungs and reservoirs at 
tidal volumes at 15 ml kg - ‘, rate between 3 and 
5 breaths min - ‘, and inspiratory: expiratory- 
HALOTHANE ADMINISTRATION DURING LIQUID VENTILATION 25 7 
timing of 1:3 using manually operated clamps. 
This ventilatory schema was based on previous 
studies of LV which demonstrated effective 
oxygenation and carbon dioxide elimination 
(2,13). In addition to neat PFC, animals were 
ventilated with a solution of PFC and halothane 
PFC:hal (see Protocol). The PFC was mixed 
with liquid halothane (Halothane USP) at con- 
centrations equivalent to 1.50 volume/vapour 
calculated by using the molecular weight and 
density of halothane (14). 
PROTOCOL AND DATA ANALYSIS 
Following surgical instrumentation, the animals 
were paralysed and stabilized with mechanical 
gas ventilation. Arterial blood gases were 
assessed and blood pressure and HR were con- 
tinuously recorded throughout the entire proto- 
col. Blood pressure response to a 2 s foot-clamp 
stimulation was used to evaluate the level of 
analgesia. 
Initial baseline studies were performed in two 
animals: one animal was ventilated for four 
cycles alternating between neat PFC and gas to 
evaluate cardiopulmonary and gas exchange 
stability over time; another animal was venti- 
lated for two cycles alternating between PFC: 
ha1 mixture and gas to examine the independent 
time course of PFC:hal and return of baseline 
physiological parameters. Five animals were 
ventilated in cycles alternating between gas and 
either neat PFC or PFC:hal mixture. The gas 
ventilation interval lasted 15-20 min. During 
LV, the animal received 33.5 breaths min - ’ for 
5 min (approximately 14-16 breaths). Upon 
completion of the last breath of each cycle, the 
animals were stimulated with a foot-clamp 
and blood samples were drawn for analysis. 
Metabolic or respiratory abnormalities were 
treated by ventilatory adjustments or supple- 
mental bicarbonate administration during gas 
ventilation. 
Sequential radiographs were obtained at end- 
inspiration in one animal during gas ventilation, 
neat PFC LV, and sequentially after PFC LV. 
Relative differences in opacification were used as 
a qualitative index in differences in PFC liquid in 
the lung. 
Cardiovascular and arterial blood gas par- 










FIG. 2. The black markings on the time axis repre- 
sent neat perfluorochemical ventilation; the white 
markings on the time axis represent gas ventilation. 
Mean arterial pressure (MAP: n ), arterial oxygen 
saturation (SaO,: A), carbon dioxide tension 
(PaCO,: 0) are stable over four continuous ventila- 
tion cycles lasting a total duration of 2.5 h. 
protocol. Single factor analysis of variance 
(ANOVA) was used to determine differences in 
arterial blood chemistry, mean arterial pressure 
(MAP) and HR as a function of respiratory 
medium (i.e. gas, neat PFC, PFC:hal mixture). 
ANOVA was also used to determine statistical 
difference in MAP response to foot-clamp stimu- 
lation (expressed as the percent change from the 
MAP during the respective cycle) as a function 
of analgesia. Statistical significance was accepted 
at the PcO.05 level and the Tukey’s post-hoc test 
was used to determine between which conditions 
statistical differences existed. 
Results 
Figure 2 displays the typical stability over time 
observed during alternate ventilation with gas 
and with neat PFC. Mean arterial pressure, 
PaCO, and oxygen saturations (SaO,) are not 
significantly different between cycles. 
The cardiopulmonary profiles during venti- 
lation with gas, neat PFC and PFC:hal mixture 
(mean f SE) are summarized in Table 1. There 
were no significant difference in PaO,, PaCO,, 
PH, HCO, - or HR as a function of ventilatory 
medium. Mean arterial pressure was lower 
(PcO.02) during ventilation with PFC:hal mix- 
ture as compared with neat PFC ventilation 
( - 35%) or gas ventilation ( - 3 1%). 
Figure 3 is a typical recording of baseline 
blood pressure (before foot-clamp) and the 
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PaO, (mmHg) 393.6 rt 79.3 282.9 f 52.6 353.6 f 58.9 
PaCO, (mmHg) 28.9 f 10.9 41.7 & 6.4 39.7 & 2.3 
PH (mmHg) 7.29 zt 0.01 7.16 f 0.02 7.13 f 0.02 
HCO, - (mEq 1 - ‘) 13.4 f 1.8 14.3 f 4 13 f 3.6 
MAP (mmHg) 107 f 10.9 113.4k4.9 72.7 &6.5* 
HR (beats min - ‘) 227 rt 27.5 251 f 28.6 227 f 14.0 
*P<O.O02 significantly different than neat PFC and gas ventilation, conversion factor: 
1 mmHg=0.133 kPa. 
PFC, perfluorochemical; MAP, mean arterial pressure; HR, heart rate. 
FIG. 3. Representative recording of blood pressure before and after foot-clamp stimulation (arrow) during (a) 
gas ventilation and (b) ventilation with the perfluorochemical:halothane (PFC:hal) mixture. While mean 
arterial pressure (MAP) increased in all animals after foot-clamp stimulation independent of ventilatory 
medium, the MAP response to stimulation was attenuated subsequent to PFC:hal ventilation. 
increase in blood pressure in response to foot- 
clamp stimulation during gas and PFC:hal ven- 
tilation. Mean arterial pressure increased in all 
animals after foot-clamp stimulation, indepen- 
dent of ventilatory medium. There was no differ- 
ence between this response elicited during gas 
and neat PFC ventilation, In the presence of 
halothane, the baseline blood pressure before 
stimulation was significantly lower than that 
observed for the other ventilation modalities. 
The response to foot-clamp stimulation was also 
reduced with the PFC:hal mixture as compared 
with neat PFC and gas ventilation. 
Figure 4 displays the individual values for 
MAP response (percent change from baseline 
MAP) to foot-clamp stimulation during gas 
ventilation and ventilation with PFC:hal. The 
response to foot-clamp stimulation was reduced 
FIG. 4. Mean arterial blood pressure response to 
foot-clamp stimulation with gas (0) ventilation and 
with perfluorochemicahhalothane (PFC:hal) (0) 
ventilation (calculated as percent change from 
resting values for individual animals. The blood 
pressure response to stimulation was significant 
lower with PFC:hal ventilation as compared with 
gas ventilation for all animals. 
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PLATE. 1. Radiographs of one animal during (a) gas ventilation, (b) perfluorochemical (PFC) liquid ventila- 
tion (LV), and (c) 4.75 h post LV on gas ventilation. Over time, the opacification, depicting residual liquid in 
the lung, is less. 
with the PFC:hal mixture as compared with neat (+ 1 l-9 f 2.3% SE) in comparison with the per- 
PFC and gas ventilation. Statistical analysis of cent increase in MAP for gas ventilation 
the change in MAP as a function of ventilatory (+28*6 f 3.7% SE); no significant difference was 
medium demonstrated that the increase in MAP determined between the increase in MAP 
(mean f SE) during PFC:hal was attenuated response to foot-clamp stimulation during 
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gas ventilation as compared with neat PFC 
ventilation (+ 27.2 f 54% SE). 
Plate 1 displays radiographs of one animal at 
end-inspiration with gas ventilation, LV with 
neap PFC, and subsequent gas ventilation at 
2 and 4.75 h after LV. The PFC-filled lung 
radiograph displays diffuse, homogeneous, 
opacified liquid-filled lung fields, as compared 
with the well-aerated normal gas-filled lung. The 
radiograph 2 h post-LV shows residual homo- 
geneous opacification throughout the lung fields. 
The radiograph 4.75 h post liquid ventilation 
displays even less opacification indicating less 
residual liquid in the lung. 
Discussion 
This study has shown that gas exchange and 
cardiovascular function can be supported in 
hamsters during mechanical ventilation with 
PFC. The significant decrease in resting MAP 
and MAP response to foot-clamp stimulation 
also indicates that it was possible to induce and 
maintain analgesia by PFC:halothane LV of 
hamsters. 
Since the original demonstration that mice 
could successfully breathe while submerged in 
an oxygenated PFC (16,22), there have been 
numerous bio-medical applications of the PFC 
liquid. Perfluorochemicals have been used as 
emulsions for blood substitutes (11,17,18), 
applications of liquid breathing have included 
the study of developmental physiology (1,2,19), 
temperature regulation (5,20), and in extreme 
environmental conditions such as aerospace 
(21) and diving medicine (21,23). More 
recently, studies have demonstrated the poten- 
tial of perfluorochemical urochemical LV as an 
investigational therapy in human neonates (9) 
and the advantages of LV as compared with 
gas ventilation in very preterm lambs (24). The 
use of PFC liquid has proven useful as an 
alternative respiratory medium because of its 
high solubility for oxygen and carbon dioxide, 
low surface tension, and homogeneous distribu- 
tion in the lung. In addition, the solubility of 
halothane and other halogenated hydrocarbons 
in the PFC liquid support the potential for 
induction and maintenance of analgesia during 
PFC ventilation (11). 
The uptake and distribution of anaesthetic 
gases are dependent upon the partial pressure of 
the anaesthetic delivered, solubility of the anaes- 
thetic agent, cardiac output, pulmonary and 
systematic blood flow, alveolar-venous partial 
pressure gradients, and the blood: tissue concen- 
tration gradient to allow for the deposition of 
the anaesthetic (25). In general, the concen- 
tration equilibrium between blood and the vessel 
rich group (i.e. brain) occurs in approximately 
10-l 5 min for standard gas-ventilation induc- 
tion. In the present study, all of the hamsters 
demonstrated an index of analgesia, reduced 
blood pressure responses to foot-clamp stimu- 
lation, during a single 5 min cycle of ventilation 
with the PFC:halothane mixture. There are some 
important differences associated with PFC ven- 
tilation as compared with gas ventilation which 
could explain the rapid induction and the ability 
to maintain analgesia. In a liquid-filled lung, 
there is homogeneous inflation of the lung which 
improves the surface area for gas exchange (26). 
Ventilation and perfusion with PFC breathing 
is more evenly matched as compared with 
gas ventilation (27); this factor would support 
optimal uptake of the anaesthetic agent. 
The sequential radiographs indicate that the 
PFC liquid in the lung post-liquid ventilation is 
reduced over time. The rate of removal of PFC 
liquid is related to the low vapour pressure and 
volatilization from the lung during subsequent 
gas ventilation (28,29). While it was beyond the 
scope of the present study, it is possible that 
waking times after PFC ventilation may be pro- 
portional to the rate of volatilization. Another 
method of removing the anaesthetic may incor- 
porate the solubility characteristic of halothane 
in the PFC liquid. In this respect, previous 
studies have demonstrated that the solubility of 
halothane in the PFC liquid is approximately 25 
times greater than that in blood (11); therefore, 
ventilating with neat PFC (not unlike ventilating 
with pure oxygen during gas ventilation) may 
prove useful in removing the anaesthetic from 
the animal. Theoretically, the neat PFC liquid 
could act as a sink for the anaesthetic agent and 
assist in removal. 
In summary, this study was designed to exam- 
ine whether anaesthesia could be achieved using 
liquid PFC as a vehicle for halothane. This 
experimental design did prove that as a measure 
of anaesthesia, a statistically significant decrease 
in baseline MAP and an attenuation in blood 
pressure response to stimulation was achieved 
during ventilation with the PFC:halothane 
mixture. An anaesthetic effect of neat PFC alone 
can be excluded because neither baseline nor 
foot-clamp MAP response was different as com- 
pared with gas ventilation. Further evaluation 
regarding blood levels of anaesthetic, waking 
times and defining minimal alveolar concen- 
tration need to be pursued before using this 
technique in human studies. 
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